← SynDRA
HYDRONIDONE
SynDRA canonical compound SYN0039462 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TGFB1 |
|---|
| Mechanism of action | TGF beta receptor inhibitor |
|---|
Cross-references
Synonyms
- F-351
- Liver cirrhosis, Gene Networks International
- Liver cirrhosis, Shanghai
- Liver fibrosis therapy, Shanghai Genomics
- Liver fibrosis, Gene Networks International
- Liver fibrosis, Shanghai
- 1-(4-Hydroxyphenyl)-5-methylpyridin-2(1H)-one
- N-(4-Hydroxyphenyl)-5-methyl-2-pyridone
- RXQ128313W
- RefChem:147095
- 1-(4-hydroxyphenyl)-5-methyl-1,2-dihydropyridin-2-one
- DTXCID00409877
- N-(4-HYDROXYPHENYL)-5-METHYL-2-1H-PYRIDONE
- F-351;F351
- 1-(4-Hydroxyphenyl)-5-methyl-2(1H)-pyridinone
- 1-(4-HYDROXYPHENYL)-5-METHYLPYRIDIN-2-ONE
- 1-(4-hydroxyphenyl)-5-methyl-pyridin-2-one
- 1-(4-hydroxyphenyl)-5-methyl-1H-pyridine-2-one
- 1-(4-Hydroxy-phenyl)-5-methyl-1H-pyridin-2-one
- SCHEMBL143564
- UNII-RXQ128313W
- orb1706009
- MFCD07369446
- AKOS016006473
- FH24467
- SB18945
- F351
- MS-23087
- SY480349
- DB-115847
- DB-345313
- HY-100438
- CS-0019024
- F82096
- T19694
- BRD-K41267922-001-01-4
Look up HYDRONIDONE in the interactive SynDRA portal →